Seal DW, Ehrhardt AA. 1999. Heterosexual men’s attitudes toward the female condom. AIDS Education and Prevention 11(2):93–106.

Shervington DO. 1993. The acceptability of the female condom among low-income African-American women. Journal of the National Medical Association 85(5):341–347.

Solomon L, Stein M, Flynn C, Schuman P, Schoenbaum E, Moore J, Holmberg S, Graham NM. 1998. Health services use by urban women with or at risk for HIV-1 infection: The HIV Epidemiology Research Study (HERS). Journal of Acquired Immune Deficiency Syndromes and Human and Retrovirology 17(3):253–261.

Soper DE, Shoupe D, Shangold GA, Shangold MM, Gutmann J, Mercer L. 1993. Prevention of vaginal trichomoniasis by compliant use of the female condom. Sexually Transmitted Diseases 20(3):137–139.

Stephenson J. 2000. AIDS researchers explore new drug options. Journal of the American Medical Association 283(9):1125.

Stetler HC, Granade TC, Nunez CA, Meza R, Terrell S, Amador L, George JR. 1997. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS 11(3):369–375.


Thompson KA, Malamud D, Storey BT. 1996. Assessment of the anti-microbial agent C31G as a spermicide: Comparison with nonoxynol-9. Contraception 53(5):313–318.

Trussell J, Sturgen K, Strickler J, Dominik R. 1994. Comparative contraceptive efficacy of the female condom and other barrier methods. Family Planning Perspective 26(2):66–72.


U.S. House of Representatives. 1999. Lifesaving vaccine technology act of 1999. 106th Congress, 1st Session, House of Representatives.


Valdiserri RO, Moore M, Gerber AR, Campbell CH Jr, Dillon BA, West GR. 1993. A study of clients returning for counseling after HIV testing: Implications for improving rates of return. Public Health Reports 108(1):12–18.

Van Damme L. 2000. Advances in topical microbicides (Session P104). XIII International AIDS Conference; Jul 9–Jul 14, 2000; Durban, South Africa.

Van Damme L, and Rosenberg Z. 1999. Microbicides and barrier methods in HIV prevention. AIDS 13(Suppl):S85–S92.

Vanable PA, Ostrow DG, McKirnan DJ, Taywaditep KJ, Hope BA. 2000. Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychology 19(2):134–145.

Vanchieri C. 1996. Experts plan for next generation of HIV tests. Annals of Internal Medicine 125(6):I62–63.

Voeller B and Anderson DJ. 1992. Vaginal pH and related factors in the urogenital tract and rectum that affect HIV-1 transmission (Mariposa Occasional Paper No. 16). Topanga, CA: The Mariposa Education and Research Foundation.

The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. 2000. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: A randomised trial. Lancet 356(9224):103–112.


Weinhardt LS, Carey MP, Johnson BT, Bickham NL. 1999. Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985–1997. American Journal of Public Health 89(9):1397–1405.

Weller SC. 1993. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Social Science and Medicine 36(12):1635–1644.

Witte SS, El-Bassel N, Wada T, Gray O, Wallace J. 1999. Acceptability of female condom use among women exchanging street sex in New York City. International Journal of STDs and AIDS 10(3):162–168.

Wulf D, Frost J, Darroch JE. 1999. Microbicides: A New Defense against Sexually Transmitted Diseases. Washington, DC: Alan Guttmacher Institute.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement